Skip to main content
Metro Brands Limited logo

Metro Brands Limited — Investor Relations & Filings

Ticker · METROBRAND ISIN · INE317I01021 LEI · 894500HOIH518O40VN09 BSE.NS Wholesale and retail trade
Filings indexed 974 across all filing types
Latest filing 2022-01-17 Regulatory Filings
Country IN India
Listing BSE.NS METROBRAND

About Metro Brands Limited

https://metrobrands.com/

Metro Brands Limited operates an extensive portfolio of footwear and accessory brands, including Metro, Mochi, Walkway, and Da Vinchi. The company provides a comprehensive range of products for men, women, and children across various price points, from economy to premium segments. Beyond its proprietary labels, the organization maintains strategic licensing and distribution agreements with international brands such as Crocs, FitFlop, and Fila. The business model integrates a multi-channel distribution network consisting of exclusive brand outlets, multi-brand outlets, and digital commerce platforms. Key operations focus on product design, sourcing, and retail management, supported by a centralized supply chain designed to meet diverse consumer preferences in the footwear and lifestyle accessories market.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, reporting the outcome of an investors/analyst conference call held on January 17, 2022. It specifically mentions that the company participated in an earnings conference call discussing financial results for the quarter and nine months ended December 31, 2021. The document is short (1695 characters) and serves as an announcement of the conference call outcome rather than a full transcript. Therefore, it fits the category of a Call Transcript (CT) as it relates to the earnings conference call discussion, but since it does not contain the full transcript text, it is best classified as a Regulatory Filing (RNS) because it is a brief announcement of the call outcome rather than the full transcript or detailed financial report.
2022-01-17 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter and nine months ended December 31, 2021. It references Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, which mandates disclosure of financial results. The document includes newspaper publication copies of these financial results and mentions that the results were approved at a Board meeting on January 15, 2022. The document is an intimation or announcement of the financial results publication rather than the full financial report itself. It does not contain detailed financial statements or substantive financial data but rather serves as a notification to the exchanges and public about the availability of the results. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the financial results publication, not the report itself. Hence, the appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-01-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'EARNINGS PRESENTATION – Q3 & 9M FY2022' and is addressed to stock exchanges with a subject line indicating it is a presentation for an Investor/Analyst Meet. It contains detailed business highlights, financial performance metrics (Revenue, EBITDA, PAT) for Q3 and 9 months of FY22, store expansion data, and strategic information about the company. The document is a presentation format intended for investors and analysts, not a formal earnings release or quarterly report filing. It is not a brief earnings release (ER) but a detailed presentation (IP). The length is substantial (15,000 characters), and it is not merely an announcement of a report publication. Therefore, the document fits the category of an Investor Presentation (IP).
2022-01-15 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the statement of deviation or variation in the use of proceeds from an Initial Public Offer (IPO) for the quarter ended December 31, 2021. It references compliance with SEBI Listing Regulations and provides a detailed table about the use of funds raised. The document is short (3201 characters) and serves as a regulatory compliance update rather than a full financial report or detailed analysis. It does not contain financial statements or substantive financial data but rather a compliance statement about fund utilization. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement and compliance document that does not fit into more specific categories like Annual Report or Capital/Financing Update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-01-15 English
Financial Result Updates
Regulatory Filings
2022-01-15 English
Outcome of Board Meeting
Regulatory Filings
2022-01-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.